See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy
Publications for Mark Blostein
Updated daily
Loading publication list...
| # | PubMedId | Deleted | Publication |
|---|---|---|---|
| 1 | 39028040 | 0 | Najem MY, Rys RN, Laurance S, et al. Extracellular RNA Induces Neutrophil Recruitment Via Toll-Like Receptor 3 During Venous Thrombosis After Vascular Injury. J Am Heart Assoc. 2024 Jul 19:e034492. doi: 10.1161/JAHA.124.034492. |
| 2 | 34108229 | 0 | Kovacs MJ, Wells PS, Anderson DR, et al. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205. |
| 3 | 33548557 | 0 | Lee A, Gu CS, Vedantham S, et al. Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome. J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1257-1265.e2. doi: 10.1016/j.jvsv.2021.01.017. Epub 2021 Feb 4. |
| 4 | 33432589 | 0 | Bendayan M, Mardigyan V, Williamson D, et al. Muscle Mass and Direct Oral Anticoagulant Activity in Older Adults With Atrial Fibrillation. J Am Geriatr Soc. 2021 Apr;69(4):1012-1018. doi: 10.1111/jgs.16992. Epub 2021 Jan 11. |
| 5 | 32853584 | 0 | Arnold DM, Heddle NM, Cook RJ, et al. Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. Lancet Haematol. 2020 Sep;7(9):e640-e648. doi: 10.1016/S2352-3026(20)30227-1. |
| 6 | 32346486 | 0 | Legault K, Blostein M, Carrier M, et al. A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome. Pilot Feasibility Stud. 2020 Apr 25;6:52. doi: 10.1186/s40814-020-00594-1. eCollection 2020. |
| 7 | 32112441 | 0 | Avram AT, Blostein MD, Hirsch AM, et al. Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery. Am J Hematol. 2020 Jun;95(6):712-717. doi: 10.1002/ajh.25768. Epub 2020 Mar 20. |
| 8 | 31986474 | 0 | Zhang J, Toupin D, Lebel MC, et al. Development of an INR for rivaroxaban monitoring using plasma samples from patients. Thromb Res. 2020 Mar;187:122-124. doi: 10.1016/j.thromres.2020.01.009. Epub 2020 Jan 10. |
| 9 | 31380891 | 0 | Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431. |
| 10 | 30685874 | 0 | Arnold DM, Jamula E, Heddle NM, et al. Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale. Thromb Haemost. 2019 Mar;119(3):500-507. doi: 10.1055/s-0038-1677531. Epub 2019 Jan 27. |
, McMaster University